期刊文献+

人胃癌组织中SSTR2、SSTR5亚型与p-ERK的表达及其相关性 被引量:1

Correlation between SSTR2, SSTR5 and p-ERK in the tissue of human gastric cancer
原文传递
导出
摘要 目的检测生长抑素受体(SSTR)亚型SSTR2、SSTR5和p-ERK在人胃癌及正常胃组织中的mRNA和蛋白表达差异,从而探讨三者之间的相关性。方法应用免疫组化方法检测23例胃癌组织和20例正常胃组织中SSTR2、SSTR5和p-ERK的蛋白表达差异,应用real time PCR技术检测三者的mRNA表达差异。结果在蛋白水平,胃癌与胃正常组织SSTR2的表达差异无显著性(P>0.05),胃癌SSTR5的表达高于胃正常组织(P<0.05),胃癌p-ERK的表达高于胃正常组织(P<0.05);在mRNA水平,胃癌与胃正常组织SSTR2的表达差异无显著性(P>0.05),胃癌SSTR5的表达高于胃正常组织(P<0.05),胃癌ERK的表达高于胃正常组织(P<0.05);胃癌中SSTR2与ERK表达无相关性(P>0.05),SSTR5与ERK表达呈正相关(P<0.05)。结论人胃癌组织中,高表达SSTR5与p-ERK,低表达SSTR2、SSTR5与ERK在胃癌的发生发展中起重要作用,且二者之间可能通过某种机制相互关联。 Objective To detect the expression of somatostatin receptor subtypes SSTR2, SSTR5 and p-ERK at the transcription and protein levels in human gastric cancer tissues, and to investigate the correlation among them. Methods Immunohistochemistry was used to detect protein expression of SSTR2, SSTR5 and p-ERK in 23 human gastric cancer tissues and 20 human normal gastric tissues, real-time PCR was used to detect mRNA expression of them. Results At the protein level, there were not statistic differences about the expression of SSTR2 between human gastric cancer and normal gastric tissues (P〉0.05), the expression of SSTR5 and p-ERK were higher in human gastric cancer tissues than in normal gastric tissues(P〈0.05);At the transcription level, there were also not statistic differences about the expression of SSTR2 between human gastric cancer and normal gastric tissues (P〉0.05), the expression of SSTR5 and p-ERK were higher in human gastric cancer tissues than in normal gastric tissues(P〈0.05);there was no correlation between SSTR2 and ERK, there was a positive correlation between SSTR5 and ERK. Conclusion In human gastric cancer tissues, there is a higher expression of SSTR5 and p-ERK and a lower expression of SSTR2;SSTR5 and ERK play a important part in the generation and progress of human gastric cancer. There exists correlation between SSTR5 and activation of ERK through some signal pathways.
出处 《中华临床医师杂志(电子版)》 CAS 2013年第22期70-72,共3页 Chinese Journal of Clinicians(Electronic Edition)
基金 山西省晋城市科技局立项课题(200905026)
关键词 受体 生长抑素 细胞外信号调节MAP激酶类 胃肿瘤 Receptors, somatostatin Extracellular signal-regulated MAP kinases Stomach neoplasms
  • 相关文献

参考文献8

  • 1Grimberg A. Somatostatin and cancer:applying endocrinology to oncology[J].{H}CANCER BIOLOGY & THERAPY,2004.731-733.
  • 2潘骅,张弘,黄介飞,魏群.生长抑素受体1~3亚型蛋白在胃癌中的表达及临床意义[J].胃肠病学和肝病学杂志,2008,17(10):826-828. 被引量:2
  • 3张广政,刘键,王艳丽,乐晓萍,张钦宪.胃癌组织中生长抑素受体亚型mRNA的表达[J].郑州大学学报(医学版),2008,43(2):264-267. 被引量:5
  • 4Joneson T,White MA,Wigler MH. Stimulation of membrane ruffling and MAP kinase activation by distinct effectors of RAS[J].{H}SCIENCE,1996.810-812.
  • 5Alison LH,Jeffrey DK,Heather EB. Somatostatin inhibits hepatic growth hormone receptor and insulin-like growth factor I mRNA expression by activating the ERK and PI3K signaling pathways[J].{H}Journal of Molecular Endocrinology,2010.317-327.
  • 6War SA,Kumar U. Coexpression of human somatostatin receptor-2(SSTR2)and SSTR3 modulates antiproliferative signaling and apoptosis[J].J Mol Signal,2012.5.
  • 7Hagemeister AL,Kittilson JD,Bergan HE. Rainbow trout somatostatin receptor subtypes SSTR1A,SSTR1B,and SSTR2 differential y activate the extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling pathways in transfected cells[J].{H}Journal of Molecular Endocrinology,2010.317-327.
  • 8江兴松,张南征,王小友.胃癌组织SSTR亚型与P-ERK表达关系的研究[J].徐州医学院学报,2007,27(4):220-224. 被引量:2

二级参考文献20

  • 1呼闯营,易粹琼.生长抑素受体SSTR3基因对胃癌细胞生长的影响[J].临床消化病杂志,2005,17(6):282-285. 被引量:4
  • 2Cheng-Zhi Qiu,Chuan Wang,Zhong-Xin Huang,Shi-Ze Zhu,You-Yi Wu,Jian-Long Qiu.Relationship between somatostatin receptor subtype expression and clinicopathology,Ki-67,Bcl-2 and p53 in colorectal cancer[J].World Journal of Gastroenterology,2006,12(13):2011-2015. 被引量:13
  • 3Zalatnai A, Pogany. Apoptosis - induction and phosphorylation state in human pancreatic carcinoma xenografts following octreotide treatment [J]. Anticancer Res,2001,21(1A):477-480.
  • 4Seger R, Krebs EG. The MAPK signaling cascade[J]. FASEB J,1995,9(9):726-735.
  • 5Fromowitz FB, Voila MV, Chao S, et al. Ras p21 expression in the progression of breast cancer [J]. Human Pathol, 1987,18(12):1268-1275.
  • 6Cole K, Kohn E. Calcium - mediated signal transduction: biology, biochemistry, and therapy [J]. Cancer Metastasis Rev, 1994,13(1):31-44.
  • 7Duff JL, Marrero MB, Paxton WG, et al. Angiotensin Ⅱ signal transduction and the mitogen - activated protein kinase pathway[J]. Cardiovascular Res,1995,30(4):511-517.
  • 8Szepeshazi K, Schally A, Nagy A, et al. Preclinical evaluation of therapeutic effects of targeted cytotoxic analogs of somatostatin and bombesin on human gastric carcinomas [ J ]. Cancer,2003,98(7):1401-1410.
  • 9Joneson T, White MA, Wigler MH, et al. Stimulation of membrane ruffling and MAP kinase activation by distinct effectors of RAS[J]. Science,1996,271(5250):810-812.
  • 10Robinson MJ, Cobb MH. Mitogen -activated protein kinase pathways[ J ]. Curr Opin Cell Biol, 1997,9(2):180-186.

共引文献6

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部